Author: Mark Hayman
Edition:
Binding: Digital
ISBN: B0008431MM
Edition:
Binding: Digital
ISBN: B0008431MM
Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)(Food and Drug Administration): An article from: Skin & Allergy News
This digital document is an article from Skin & Allergy News, published by International Medical News Group on September 1, 2004. Get Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)(Food and Drug Administration): An article from diet books 2013 for free.
The length of the article is 725 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.
Citation Details
Title: Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)(Food and Drug Administration)
Author: Mark Hayman
Publication: Skin & Allergy News (Magazine/Journal)
Date: September 1, 2004
Publisher: Check Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)(Food and Drug Administration): An article from our best diet books for 2013. All books are available in pdf format and downloadable from rapidshare, 4shared, and mediafire.
Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)(Food and Drug Administration): An article from Free
The length of the article is 725 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase
Citation Details
Title: Should the FDA consider cost-effectiveness when approving new drug applications?(Pro & Con)(Food and Drug Administration)
Author: Mark Hayman
Publication: Skin & Allergy News (Magazine/Journal)
Date: September 1, 2004
Publisher:
No comments:
Post a Comment